Glutamatergic mechanisms in different disease states: overview and therapeutical implications -- an introduction.
about
The excitatory neurotransmitter glutamate stimulates DNA repair to increase neuronal resiliencyProtection of SH-SY5Y neuronal cells from glutamate-induced apoptosis by 3,6'-disinapoyl sucrose, a bioactive compound isolated from Radix PolygalaThe glutamatergic system as a target for neuropathic pain reliefIn situ-produced 7-chlorokynurenate has different effects on evoked responses in rats with limbic epilepsy in comparison to naive controls.Neuropsychopharmacology of auditory hallucinations: insights from pharmacological functional MRI and perspectives for future research.Evidence of altered polyamine concentrations in cerebral cortex of suicide completersKEL-8 is a substrate receptor for CUL3-dependent ubiquitin ligase that regulates synaptic glutamate receptor turnover.Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine.Effect of glycine site/NMDA receptor antagonist MRZ2/576 on the conditioned place preference and locomotor activity induced by morphine in miceLoss of hrs in the central nervous system causes accumulation of ubiquitinated proteins and neurodegenerationMicroelectrode array studies of basal and potassium-evoked release of L-glutamate in the anesthetized rat brain.The influence of glutamatergic antagonism on motor variability, and comparison to findings in schizophrenia patients.Reward related neurotransmitter changes in a model of depression: An in vivo microdialysis study.A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory.Increased Absolute Glutamate Concentrations and Glutamate-to-Creatine Ratios in Patients With Methamphetamine Use Disorders
P2860
Q24611547-DD43E453-C957-4F6D-BC40-C5DD996345C1Q24622211-07C604DE-26CC-4CAA-9196-79E3A1013B45Q27006077-43524666-9337-461A-B2A8-E2351F5CB7F4Q30438764-AD560957-4F56-41ED-B883-ECD270C2D56AQ30582343-DB4413B2-D833-4A18-B31D-E983C4EDC2A2Q33868443-BC641231-0591-4CDC-A736-AF3920935226Q34407303-2BEF00BD-0193-4878-83FB-509CFF395721Q34714448-42FB4A67-7297-4F98-A295-C5122862FCFFQ35166858-AA4D8A67-6559-4776-AFB4-265B8F5CA8B4Q42046014-FA53E998-BF11-437C-A205-8E4F9FCBE364Q42490021-B97E2035-C363-401B-BD4D-BB034D122133Q42686680-83DAA5CE-A872-4DF1-A3E7-A0CC6A18C9FCQ48073091-36589907-C339-417D-A1F8-9273BFDDAE4EQ48271960-99F541FE-2C6E-45D1-8354-D1AF97BA0341Q58780691-FF0E8C6D-1F2C-48C6-BDF2-3B6557631A2F
P2860
Glutamatergic mechanisms in different disease states: overview and therapeutical implications -- an introduction.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Glutamatergic mechanisms in di ...... plications -- an introduction.
@ast
Glutamatergic mechanisms in di ...... plications -- an introduction.
@en
Glutamatergic mechanisms in di ...... plications -- an introduction.
@nl
type
label
Glutamatergic mechanisms in di ...... plications -- an introduction.
@ast
Glutamatergic mechanisms in di ...... plications -- an introduction.
@en
Glutamatergic mechanisms in di ...... plications -- an introduction.
@nl
prefLabel
Glutamatergic mechanisms in di ...... plications -- an introduction.
@ast
Glutamatergic mechanisms in di ...... plications -- an introduction.
@en
Glutamatergic mechanisms in di ...... plications -- an introduction.
@nl
P1433
P1476
Glutamatergic mechanisms in di ...... plications -- an introduction.
@en
P2093
Tzschentke TM
P2888
P304
P356
10.1007/S00726-001-0120-8
P577
2002-01-01T00:00:00Z